Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 18 U

First Page		Document Content
Date: 2007-04-16 09:09:09 GlaxoSmithKline Fluticasone/salmeterol Chronic lower respiratory diseases Organofluorides Salmeterol Fluticasone propionate Chronic obstructive pulmonary disease Pulmonology Respiratory therapy Medicine		Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 18 U Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 12,24 KB Share Document on Facebook

	Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No DocID: 1rqYi - View Document
	Microsoft WordDOCX DocID: 1rnqZ - View Document
	Beilage 1: Arzneimittelmonographien DocID: 1rinj - View Document
	SAFETY DATA SHEET Page 1 of Total 6 Date of Issue: August 2016 SDS No. FMC/RAD/1 SECTION 1 DocID: 1rdYu - View Document
	imatinib and colon cancer. imatinib availability imatinib and cml imatinib and tight junction cancer imatinib prostate dercum and imatinib zactima plus imatinib DocID: 1rdbp - View Document